je.st
news
Tag: accepts
Monsanto accepts $66bn Bayer takeover
2016-09-14 12:20:08| BBC News | Business | UK Edition
The BBC has learned that US seeds giant Monsanto has accepted a takeover offer from Germany's Bayer in a deal that would create the world's biggest seeds and pesticides company.
Tags: accepts
bayer
takeover
monsanto
CSD Editor Kurt Lawton accepts Ruth White Media Award
2016-09-13 21:46:00| Corn & Soybean Digest
Mid America CropLife Association Kurt Lawton's goal is to get the farming community to think differently. The Ruth White Media Award is presented to an individual whos demonstrated accurate reporting on American agriculture. read more
Tags: media
white
editor
award
California ISO Accepts Tariff Revisions for 'Grid Reliability'
2016-09-07 19:31:00| Transmission & Distribution World
The California Independent System Operator Board of Governors has accepted proposed tariff revisions that will ensure solar, wind and battery storage resources can provide needed grid services read more
Tags: california
iso
accepts
reliability
FDA Accepts Supplemental Biologics License Application, Assigns Priority Review and Grants Breakthrough Therapy Designation to Mercks KEYTRUDA (pembrolizumab) for First-Line Treatment of Patients with Advanced Non-Small Cell Lung Cancer
2016-09-07 12:45:00| Merck.com - Product News
Dateline City: KENILWORTH, N.J. Merck Has Also Submitted a Marketing Authorization Application to the European Medicines Agency for KEYTRUDA in the Same Patient Population Submissions Based on Data from KEYNOTE-024 Trial Showing Superior Progression-Free and Overall Survival Compared to Chemotherapy in Patients Whose Tumors Express High Levels of PD-L1 KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics License Application (sBLA) for KEYTRUDA (pembrolizumab), the companys anti-PD-1 therapy, for the first-line treatment of patients with advanced non-small cell lung cancer (NSCLC) whose tumors express PD-L1, with a PDUFA, or target action, date of Dec. 24, 2016. Language: English Contact: MerckMedia:Pamela Eisele, 267-305-3558orCourtney Ronaldo, 908-236-1108orInvestors:Teri Loxam, 908-740-1986orAmy Klug, 908-740-1898 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: advanced
review
application
license
EU accepts commitments by Paramount on cross-border pay-TV services
2016-07-26 12:00:20| Digital TV News
Paramount has committed that within the EEA it will not enforce clauses restricting the ability of broadcasters to accept unsolicited requests for their pay-TV services from consumers located outside their licensed territory.
Tags: services
accepts
commitments
paramount
Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] next »